Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
News Release
Mitchell Diagnostics Platform Surpasses 3 Million Scans
SAN DIEGO, CA—November 3, 2021—Mitchell, a leading provider of technology, connectivity and information solutions to the
Mitchell
News Release
Mitchell Named Official Technology Provider of the Vale Paintless Dent Repair (PDR) Technician Certification Program
SAN DIEGO, CA—October 26, 2021—Mitchell, a leading provider of technology, connectivity and information solutions to the
Enlyte
Article
FDA Approves Combination NSAID/Opioid Seglentis
On October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA).
Enlyte
Article
FDA Approves Combination NSAID/Opioid Seglentis
On October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA).
PDF
Article
Specialty Services Are a Big Deal
When adjusters have to jump through hoops to make referrals, they lose precious time.
Mitchell
Virtual Event
Navigating Michigan’s No-Fault Auto Fee Schedule Four Months In
On-Demand
On July 2, 2021, Michigan’s new auto fee schedule went into effect for services rendered on or after that date.